Anti-SARS-CoV-2 IgG of severely ill COVID-19 patients induces hyper-inflammation that can be specifically counteracted by FDA/EMA-approved small molecule inhibitors

Geyer, C. E.; Chen, H. J.; Caniels, T.; Manz, X. D.; Griffith, G. R.; Hoepel, W.; Bijl, T.; Guerra, D.; de Taeye, S. W.; Aman, J.; Veth, J.; Bonta, P. I.; Jonkers, R. E.; Vidarsson, G.; van Gils, M. J.; de Winther, M. P. J.; den Dunnen, J.

Geyer, C. E.; Chen, H. J.; Caniels, T.; Manz, X. D.; Griffith, G. R.; Hoepel, W.; Bijl, T.; Guerra, D.; de Taeye, S. W.; Aman, J.; Veth, J.; Bonta, P. I.; Jonkers, R. E.; Vidarsson, G.; van Gils, M. J.; de Winther, M. P. J.; den Dunnen, J..

European Journal of Immunology ; 52:21-21, 2022.

Article in English | Web of Science | ID: covidwho-2230316

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Language: English Journal: European Journal of Immunology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

Collection: Databases of international organizations Database: Web of Science Language: English Journal: European Journal of Immunology Year: 2022 Document Type: Article